MZMichael Zohney

Michael Zohney

*This is an algorithmically generated author record based on publicly available information.

Michael Zohney has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Recurrent Pituitary Neuroendocrine Tumors: Anatomical Predictors of Gross-Total Resection With a Proposed Pituitary Resectability Score

    by Michael Zohney, Mohamed Helmy Abd Elshafouk, Mohamed M. Aziz, Mohamed Awad Mohamed Ismail, Khaled El-Bahy

  • Open Access

    Beyond the triad: akinetic mutism in idiopathic normal pressure hydrocephalus, with response to shunt placement. Illustrative case

    by Moustafa A. Mansour, Ahmed Refaat, Ahmed M. Kamer-Eldawla, Michael Zohney, Mohamed El-Batanony, Mohammad M. Selim, Ahmed M. Elshaer, Hamdi Nabawi Mostafa

    BACKGROUND: Idiopathic normal pressure hydrocephalus (iNPH) typically manifests with the classic Hakim-Adams triad of gait disturbance, cognitive impairment, and urinary incontinence. While akinetic mutism represents a rare and severe neurological presentation characterized by profound reduction in voluntary movement and speech, its association with iNPH remains underrecognized in clinical practice. This case illustrates both the diagnostic challenges and remarkable therapeutic potential when encountering this unusual manifestation of iNPH. OBSERVATIONS: A previously healthy 52-year-old female developed progressive gait instability, urinary incontinence, and cognitive decline over 6 months, followed by 3 months of akinetic mutism. Examination demonstrated characteristic features of iNPH including paratonic rigidity, magnetic gait, and frontal release signs. Neuroimaging revealed moderate ventriculomegaly with an Evans index of 0.38 and hyperdynamic CSF flow dynamics (peak velocity 7.4 cm/sec, stroke volume 95 µL). The patient exhibited dramatic clinical improvement within 1 week of ventriculoperitoneal shunt placement, with complete resolution of akinetic mutism and significant recovery of other symptoms sustained at the 6-month follow-up. LESSONS: This case underscores that akinetic mutism, while uncommon, may represent a severe but treatable manifestation of iNPH. The rapid reversal of akinetic mutism following CSF diversion highlights the importance of considering iNPH even in atypical presentations. Quantitative CSF flow analysis emerges as a valuable diagnostic tool in such challenging cases, while the striking clinical response reinforces the potential for complete functional recovery with timely intervention. https://thejns.org/doi/10.3171/CASE25257

  • Open Access

    Neurosurgery reimagined: How AI is redefining patient care and surgical excellence

    by Moustafa A. Mansour, Mohamed Abdel-Fattah El-Salamoni, Michael Zohney, Ahmed M. Elshaer, Moataz Abdelwahab, Mohamed M. Aziz, Basim Ayoub, Hamdi Nabawi Mostafa, Amr El-Samman


  • Open Access

    Shunt-related brain tumor, a case report presenting a rare complication and review of literature

    by Michael Zohney, Mohamed M Aziz, Shebl Izz-Alarab, Ahmed A Algredly, Abdelaleem Abdelwahab

    Background: Congenital hydrocephalus is a well-known neurosurgical condition in the pediatric age group. Ventriculoperitoneal shunt (VPS) placement is a standard procedure with a high incidence of complications in the first year postoperatively. We present a very rare complication, with only a few reported cases in the accessible literature, in which a tumor arises in relation to a shunt catheter. Study design: A case report. Case presentation: We describe a case of a VPS placement in an eleven-month-old boy who, at the age of thirteen, presented with a two-month period of convulsions caused by a cortical mass related to the shunt catheter. Surgical excision of the mass revealed atypical meningioma (WHO Grade 2). Conclusions: The tumor may have been initiated by direct irritation of the shunt catheter or just an unfortunate simultaneous event for this child. Further analysis is needed to determine which factors could have led to such a complication and to predict its occurrence in future patients. In this case, the pathologic features, duration, and unusual radiologic findings are interesting and unique.

  • Open Access

    Surgical outcome of endoscopic endonasal approach as a modality of management for large and giant pituitary adenomas: a retrospective case series

    by Shebl Izz-Alarab, Michael Zohney, Saied A. Issa, Abdelaleem Abdelwahab, Ashraf G. Al-Abyad, Mohamed M. Aziz

    Background: Large and giant pituitary adenomas (defined as tumors of maximal diameter ≥ 3–3.9 cm and ≥ 4 cm, respectively) present considerable surgical challenges regarding the extent of resection and perioperative morbidity. Endoscopic endonasal resection is considered the most effective treatment for pituitary adenomas. It allows for better visualization, maneuverability, and access to distant and lateral tumor compartments, ultimately enhancing the extent of resection. This article evaluates our initial experience with endoscopic endonasal resection of large and giant pituitary adenomas. The clinical outcomes, perioperative complications, and extent of tumor resection would be specifically addressed. Patients and methods: The primary goal of surgery was to decompress the optic pathways, and the secondary goals were to achieve maximal safe resection and hormonal control in hormone-secreting adenomas. The degree of tumor resection was classified as gross-total resection (100%), near-total resection (90–100%), subtotal resection (70–90%), and partial resection (< 70%). Results: 42 patients were included in this study. A good visual outcome achieved with 80% improvement in visual symptoms. Gross-total resection (GTR) was achieved in 19 patients (45.2%), near-total resection (NTR) was achieved in 12 patients (28.6%), subtotal resection (STR) in 6 patients (14.3%), and partial resection in the remaining 5 patients (11.9%). Subgroup analysis revealed that GTR, NTR rates were higher in large, compared to giant tumors. GTR, NTR rates of large adenomas were 59.3%, and 29.6%, compared to 20%, and 26.7% in giant adenomas respectively (p-value: 0.01428). Surgical complications were observed in 19 patients (45.2%) with CSF leakage being the most common complication (11 patients, 26.2%). Post-operative diabetes insipidus was observed in 5 patients (11.9%), major vascular injury in one case (2.4%), transient post-op 6th nerve palsy observed in 3 patients (7.1%), while two patients (4.8%) presented with post-operative paranasal sinuses infection. Conclusions: Endoscopic endonasal transsphenoidal resection of large and giant pituitary adenomas is a safe and efficient procedure. Large adenomas (3–3.9 cm) have excellent resection rates and lower complications than giant adenomas (≥ 4 cm), which may require extending our approach to achieve more tumor resection rates in the future. However, only adequate resection of these giant adenomas can be enough to achieve the main surgical goals of visual improvement, hormonal control, and decompression of surrounding structures.


  • Prognostic Factors for Survival in Adult Patients with Cerebral Low-Grade Glioma

    by Ashraf G Al-Abyad, Hesham A Abdelraheem, Hesham M Radwan, Michael Z Johny

    Low-grade gliomas are considered a therapeutic dilemma because of the heterogeneity of their clinical behavior. Patients affected by these tumors are often young and management decisions should put into consideration the potential indolent nature of these tumors and the potential long-term side effects of available therapies. to analyze the collective data from studies to define prognostic factors for overall survival in adult patients with cerebral low-grade gliomas. We prepared this systematic review with a careful following of the Cochrane Handbook for Systematic Reviews of Interventions guidelines. We conducted a literature search till December 2020 using PubMed, Scopus, Web of Science, and Cochrane Library. We performed a search for all published articles that evaluated the impact of several factors (patient’s age, KPS, neurological symptoms, histological subtype, pre-op tumor size, tumor crossing the midline, tumor enhancement, extent of resection, radiotherapy, and chemotherapy) on the overall survival (OS) and progression-free survival (PFS) of adult patients with cerebral low-grade glioma (LGG), Studies were independently assessed for risk of bias using (Cochrane Risk of Bias 2.0) for randomized controlled trials, and (Newcastle–Ottawa Scale) for retrospective cohort studies. Patient-related factors (age was found significant according to 14 of total 19 studies, KPS according to 7 of total 11 studies, and presence of seizures according to 5 of total 7 studies). Tumor-related factors (tumor subtype was significant according to 10 of total 13 studies, IDH-mutation according to 4 of total 5 studies, 1p/19q codeletion according to 5 of total 5 studies, and tumor enhancement according to 4 of total 7 studies), and treatmentrelated factors (extent of resection was significant according to 18 of total 20 studies, while timing and dose of radiation, combined chemotherapy and radiotherapy failed to show major statistical significance, with better PFS in delayed radiotherapy “till progression”, and slightly better OS in combined chemo, radiotherapy). Highly significant factors are extent of tumor resection, patient’s age, pre-op tumor volume and molecular subtype.